KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Merck (MRK) EPS (Basic) (2016 - 2026)

Merck has reported EPS (Basic) over the past 18 years, most recently at -$1.72 for Q1 2026.

  • Quarterly EPS (Basic) fell 185.57% to -$1.72 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.57 through Mar 2026, down 48.19% year-over-year, with the annual reading at $7.3 for FY2025, 7.99% up from the prior year.
  • EPS (Basic) was -$1.72 for Q1 2026 at Merck, down from $1.21 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $2.32 in Q3 2025 and troughed at -$2.35 in Q2 2023.
  • The 5-year median for EPS (Basic) is $1.48 (2024), against an average of $1.07.
  • Year-over-year, EPS (Basic) crashed 250.64% in 2023 and then surged 402.04% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at $1.18 in 2022, then plummeted by 141.53% to -$0.49 in 2023, then surged by 402.04% to $1.48 in 2024, then decreased by 18.24% to $1.21 in 2025, then plummeted by 242.15% to -$1.72 in 2026.
  • Per Business Quant, the three most recent readings for MRK's EPS (Basic) are -$1.72 (Q1 2026), $1.21 (Q4 2025), and $2.32 (Q3 2025).